Earnings Feed
Sign Up
Home/Insiders/Chambon Philippe O.
CP
SEC Insider//CIK 0001192212

Chambon Philippe O.

CIK 000119221215 companiesNEW YORK, NY
SEC Profile

Transactions

50

Companies

15

Filings

8

CIK

0001192212

Recent Transactions

50 trades
  • Conversion
    iRhythm Technologies, Inc.$IRTC

    Common Stock

    2016-10-25+1,716,589→ 1,716,589 total
  • Purchase
    iRhythm Technologies, Inc.$IRTC

    Common Stock

    2016-10-25$17.00/sh+25,000→ 1,741,589 total
  • Conversion
    iRhythm Technologies, Inc.$IRTC

    Series D Preferred Stock Warrant (Right to Buy)

    2016-10-25−72,389→ 0 total
  • Conversion
    iRhythm Technologies, Inc.$IRTC

    Series E Convertible Preferred Stock

    2016-10-25−155,548→ 0 total
  • Conversion
    iRhythm Technologies, Inc.$IRTC

    Series C Convertible Preferred Stock

    2016-10-25−610,136→ 0 total
  • Conversion
    iRhythm Technologies, Inc.$IRTC

    Series D Convertible Preferred Stock

    2016-10-25−190,154→ 0 total
  • Sale
    Lite Strategy, Inc.$LITS

    Common Stock

    2015-03-24$1.97/sh−1,601,390→ 0 total
  • Sale
    Aravive, Inc.

    Common Stock

    2014-12-18$19.01/sh−150,000→ 2,409,374 total
  • Sale
    Lite Strategy, Inc.$LITS

    Common Stock

    2014-12-09$6.01/sh−70,081→ 1,601,390 total
  • Sale
    Lite Strategy, Inc.$LITS

    Common Stock

    2014-12-08$6.05/sh−9,004→ 1,671,471 total
  • Disposition to Issuer
    Durata Therapeutics, Inc.

    Common Stock

    2014-11-17−3,028,439→ 0 total
  • Sale
    Aravive, Inc.

    Common Stock

    2014-11-11$19.37/sh−800,000→ 2,559,374 total
  • Sale
    Aravive, Inc.

    Common Stock

    2014-09-29$20.02/sh−12,556→ 3,359,374 total
  • Conversion
    Aravive, Inc.

    Series D2 Convertible Preferred Stock

    2014-03-27−1,349,433→ 0 total
  • Exercise of In-Money
    Aravive, Inc.

    Warrant

    2014-03-27−759,565→ 0 total
  • Conversion
    Aravive, Inc.

    Series E Convertible Preferred Stock

    2014-03-27−3,546,094→ 0 total
  • Conversion
    Aravive, Inc.

    Common Stock

    2014-03-27+1,821,084→ 1,821,084 total
  • Conversion
    Aravive, Inc.

    Series D1 Convertible Preferred Stock

    2014-03-27−3,050,019→ 0 total
  • Conversion
    Aravive, Inc.

    Common Stock

    2014-03-27+308,356→ 3,245,881 total
  • Conversion
    Aravive, Inc.

    Series B Convertible Preferred Stock

    2014-03-27−759,565→ 0 total
  • Conversion
    Aravive, Inc.

    Common Stock

    2014-03-27+265,219→ 2,820,183 total
  • Conversion
    Aravive, Inc.

    Common Stock

    2014-03-27+117,342→ 2,937,525 total
  • Purchase
    Aravive, Inc.

    Common Stock

    2014-03-27$21.02/sh+60,000→ 3,371,930 total
  • Conversion
    Aravive, Inc.

    Common Stock

    2014-03-27+66,049→ 3,311,930 total
  • Conversion
    Aravive, Inc.

    Common Stock

    2014-03-27+733,880→ 2,554,964 total
  • Conversion
    Aravive, Inc.

    Series C Convertible Preferred Stock

    2014-03-27−8,439,620→ 0 total
  • Conversion
    Aravive, Inc.

    Series B Convertible Preferred Stock

    2014-03-27−20,942,466→ 0 total
  • Other
    CHIMERIX INC

    Common Stock

    2014-03-18−700,000→ 1,543,394 total
  • Conversion
    CONCERT PHARMACEUTICALS, INC.

    Series B Preferred Stock

    2014-02-19+442,478→ 0 total
  • Conversion
    CONCERT PHARMACEUTICALS, INC.

    Series C Preferred Stock

    2014-02-19+77,522→ 0 total
  • Conversion
    CONCERT PHARMACEUTICALS, INC.

    Common Stock

    2014-02-19+78,315→ 93,606 total
  • Conversion
    CONCERT PHARMACEUTICALS, INC.

    Common Stock

    2014-02-19+13,721→ 107,327 total
  • Sale
    Lite Strategy, Inc.$LITS

    Common Stock

    2013-11-21$8.25/sh−365,000→ 1,680,475 total
  • Purchase
    Relypsa Inc

    Common Stock

    2013-11-20$11.00/sh+185,978→ 2,114,890 total
  • Conversion
    Relypsa Inc

    Series B-2 Preferred Stock

    2013-11-20−378,773→ 0 total
  • Exercise/Conversion
    Relypsa Inc

    Warrant to Purchase Common Stock

    2013-11-20−25,977→ 0 total
  • Conversion
    Relypsa Inc

    Series A-1 Preferred Stock

    2013-11-20−497,093→ 0 total
  • Conversion
    Relypsa Inc

    Series C-2 Preferred Stock

    2013-11-20−125,067→ 0 total
  • Conversion
    Relypsa Inc

    Common Stock

    2013-11-20+381,733→ 878,826 total
  • Conversion
    Relypsa Inc

    Common Stock

    2013-11-20+125,067→ 1,924,626 total
  • Conversion
    Relypsa Inc

    Common Stock

    2013-11-20+541,960→ 1,799,559 total
  • Tax Payment
    Relypsa Inc

    Common Stock

    2013-11-20$11.00/sh−21,691→ 1,928,912 total
  • Conversion
    Relypsa Inc

    Common Stock

    2013-11-20+497,093→ 497,093 total
  • Conversion
    Relypsa Inc

    Series B-1 Preferred Stock

    2013-11-20−259,676→ 0 total
  • Conversion
    Relypsa Inc

    Common Stock

    2013-11-20+378,773→ 1,257,599 total
  • Other
    Relypsa Inc

    Warrant to Purchase Common Stock

    2013-11-20+25,977→ 25,977 total
  • Exercise/Conversion
    Relypsa Inc

    Common Stock

    2013-11-20$9.18/sh+25,977→ 1,950,603 total
  • Conversion
    Relypsa Inc

    Series C-1 Preferred Stock

    2013-11-20−541,960→ 0 total
  • Other
    Relypsa Inc

    Warrant to Purchase Preferred Stock

    2013-11-20−17,671→ 0 total
  • Sale
    Lite Strategy, Inc.$LITS

    Common Stock

    2013-05-08$8.45/sh−100,000→ 2,045,475 total

Companies

15

Recent Filings

8

Address

C/O NEW LEAF VENTURE MGMT I, L.L.C. TIMES SQUARE TWR, 7 TIMES SQ, SUITE 1603

NEW YORK, NY, 10036

View on SEC.gov